Anthony B. Brureau
Evry, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.
Journal: JCI insight
Published: September 09, 2025
Transgene-induced cardiotoxicity in high-dose AAV gene transfer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 26, 2025
High-throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin-deficient limb girdle muscular dystrophy.
Journal: British journal of pharmacology
Published: April 19, 2024
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
Journal: Journal of neuroscience research
Published: February 05, 2020
NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration.
Journal: Neurobiology of disease
Published: December 13, 2016
Two-Photon Holographic Stimulation of ReaChR.
Journal: Frontiers in cellular neuroscience
Published: July 08, 2016
Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model.
Journal: Neurobiology of aging
Published: August 02, 2012
Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in rats.
Journal: PloS one
Published: May 24, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026